Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Senate Passes FY 19 Ag/FDA Funding as Part of 4-bill Mini-bus Read More Advocacy at a Glance STEVEN GROSSMAN 5/11/18 Advocacy at a Glance STEVEN GROSSMAN 5/11/18 House Appropriations Bill Provides FDA with a $300+ Million Increase and more Read More Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Congress Unveils Final FY 18 Consolidated Appropriations Bill; FDA Funding Increased and more Read More Advocacy at a Glance STEVEN GROSSMAN 1/19/18 Advocacy at a Glance STEVEN GROSSMAN 1/19/18 Government Shutdown Seems Likely Read More Advocacy at a Glance STEVEN GROSSMAN 6/9/17 Advocacy at a Glance STEVEN GROSSMAN 6/9/17 Questions About FDA and the Federal Budget and more Read More Analysis and Commentary STEVEN GROSSMAN 5/26/17 Analysis and Commentary STEVEN GROSSMAN 5/26/17 The Good News; the Bad News; and What's Next? Read More Analysis and Commentary STEVEN GROSSMAN 5/12/17 Analysis and Commentary STEVEN GROSSMAN 5/12/17 Proposed FDA FY 18 Budget Swap a Non-Starter Read More
Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Senate Passes FY 19 Ag/FDA Funding as Part of 4-bill Mini-bus Read More
Advocacy at a Glance STEVEN GROSSMAN 5/11/18 Advocacy at a Glance STEVEN GROSSMAN 5/11/18 House Appropriations Bill Provides FDA with a $300+ Million Increase and more Read More
Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Congress Unveils Final FY 18 Consolidated Appropriations Bill; FDA Funding Increased and more Read More
Advocacy at a Glance STEVEN GROSSMAN 1/19/18 Advocacy at a Glance STEVEN GROSSMAN 1/19/18 Government Shutdown Seems Likely Read More
Advocacy at a Glance STEVEN GROSSMAN 6/9/17 Advocacy at a Glance STEVEN GROSSMAN 6/9/17 Questions About FDA and the Federal Budget and more Read More
Analysis and Commentary STEVEN GROSSMAN 5/26/17 Analysis and Commentary STEVEN GROSSMAN 5/26/17 The Good News; the Bad News; and What's Next? Read More
Analysis and Commentary STEVEN GROSSMAN 5/12/17 Analysis and Commentary STEVEN GROSSMAN 5/12/17 Proposed FDA FY 18 Budget Swap a Non-Starter Read More
